Bob Hariri, M.D., Ph.D., is the vice chairman of Human Longevity Inc. , a genomics and cell-therapy diagnostics and therapeutics company he co-founded in 2013 with Craig Venter and Peter Diamandis, which is focused on extending the healthy, high-performance human lifespan. Utilizing technological advancements in genomics, bioinformatics, computing and cell therapy, HLI plans to develop therapeutic solutions to some of the most complex yet actionable diseases, such as cancer, heart disease and dementia.
http://ift.tt/1rmovZd
http://ift.tt/1rmovZd
No comments:
Post a Comment